| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| 2413.T - M3, Inc. | HOLD | 0 @ JPY 13.427 | JPY 0 | The current share valuation price of 2413.T based on adjusted close was JPY 13.427. The average price that 2413.T shares were previous bought at was JPY 14.2974. The current market price is -6.1% lower than average price they were purchased at. The value of the holding in 2413.T has increased by JPY 8,241 (USD $53) compared to the previous valuation of M3, Inc. however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| 4151.T - Kyowa Kirin Co., Ltd. | HOLD | 0 @ JPY 16.5161 | JPY 0 | The current share valuation price of 4151.T based on adjusted close was JPY 16.5161. The average price that 4151.T shares were previous bought at was JPY 15.9178. The current market price is 3.8% higher than average price they were purchased at. The value of the holding in 4151.T has increased by JPY 2,609 (USD $17) compared to the previous valuation of Kyowa Kirin Co., Ltd. however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| 4502.T - Takeda Pharmaceutical Company Limited | HOLD | 0 @ JPY 28.8341 | JPY 0 | The current share valuation price of 4502.T based on adjusted close was JPY 28.8341. The average price that 4502.T shares were previous bought at was JPY 28.8244. The current market price is 0.0% higher than average price they were purchased at. The value of the holding in 4502.T has fallen by JPY 1,982 (USD $13) compared to the previous valuation of Takeda Pharmaceutical Company Limited |
| 4503.T - Astellas Pharma Inc. | HOLD | 0 @ JPY 13.6102 | JPY 0 | The current share valuation price of 4503.T based on adjusted close was JPY 13.6102. The average price that 4503.T shares were previous bought at was JPY 11.3001. The current market price is 20.4% higher than average price they were purchased at. The value of the holding in 4503.T has increased by JPY 20,546 (USD $132) compared to the previous valuation of Astellas Pharma Inc. however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| 4507.T - Shionogi & Co., Ltd. | HOLD | 0 @ JPY 17.609 | JPY 0 | The current share valuation price of 4507.T based on adjusted close was JPY 17.609. The average price that 4507.T shares were previous bought at was JPY 17.0705. The current market price is 3.2% higher than average price they were purchased at. The value of the holding in 4507.T has increased by JPY 1,922 (USD $12) compared to the previous valuation of Shionogi & Co., Ltd. however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| 4519.T - Chugai Pharmaceutical Co., Ltd. | HOLD | 0 @ JPY 52.66 | JPY 0 | The current share valuation price of 4519.T based on adjusted close was JPY 52.66. The average price that 4519.T shares were previous bought at was JPY 47.9773. The current market price is 9.8% higher than average price they were purchased at. The value of the holding in 4519.T has increased by JPY 4,260 (USD $27) compared to the previous valuation of Chugai Pharmaceutical Co., Ltd. however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| 4523.T - Eisai Co., Ltd. | HOLD | 0 @ JPY 29.4641 | JPY 0 | The current share valuation price of 4523.T based on adjusted close was JPY 29.4641. The average price that 4523.T shares were previous bought at was JPY 30.3171. The current market price is -2.8% lower than average price they were purchased at. The value of the holding in 4523.T has increased by JPY 45,161 (USD $290) compared to the previous valuation of Eisai Co., Ltd. however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| 4543.T - Terumo Corporation | HOLD | 0 @ JPY 15.0439 | JPY 0 | The current share valuation price of 4543.T based on adjusted close was JPY 15.0439. The average price that 4543.T shares were previous bought at was JPY 16.204. The current market price is -7.2% lower than average price they were purchased at. The value of the holding in 4543.T has increased by JPY 4,961 (USD $32) compared to the previous valuation of Terumo Corporation however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| 4568.T - Daiichi Sankyo Company, Limited | HOLD | 0 @ JPY 21.4793 | JPY 0 | The current share valuation price of 4568.T based on adjusted close was JPY 21.4793. The average price that 4568.T shares were previous bought at was JPY 23.7402. The current market price is -9.5% lower than average price they were purchased at. The value of the holding in 4568.T has fallen by JPY 200,125 (USD $1,287) compared to the previous valuation of Daiichi Sankyo Company, Limited |
| 4578.T - Otsuka Holdings Co., Ltd. | HOLD | 0 @ JPY 59.4684 | JPY 0 | The current share valuation price of 4578.T based on adjusted close was JPY 59.4684. The average price that 4578.T shares were previous bought at was JPY 54.7568. The current market price is 8.6% higher than average price they were purchased at. The value of the holding in 4578.T has increased by JPY 875 (USD $6) compared to the previous valuation of Otsuka Holdings Co., Ltd. however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| 6869.T - Sysmex Corporation | HOLD | 0 @ JPY 10.0325 | JPY 0 | The current share valuation price of 6869.T based on adjusted close was JPY 10.0325. The average price that 6869.T shares were previous bought at was JPY 11.7732. The current market price is -14.8% lower than average price they were purchased at. The value of the holding in 6869.T has increased by JPY 51,019 (USD $328) compared to the previous valuation of Sysmex Corporation however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| 7733.T - Olympus Corporation | HOLD | 0 @ JPY 12.8001 | JPY 0 | The current share valuation price of 7733.T based on adjusted close was JPY 12.8001. The average price that 7733.T shares were previous bought at was JPY 12.7389. The current market price is 0.5% higher than average price they were purchased at. The value of the holding in 7733.T has fallen by JPY 1,381 (USD $9) compared to the previous valuation of Olympus Corporation |
| 7741.T - HOYA Corporation | HOLD | 0 @ JPY 151.95 | JPY 0 | The current share valuation price of 7741.T based on adjusted close was JPY 151.95. The average price that 7741.T shares were previous bought at was JPY 145.997. The current market price is 4.1% higher than average price they were purchased at. The value of the holding in 7741.T has fallen by JPY 13,264 (USD $85) compared to the previous valuation of HOYA Corporation |
| A - Agilent Technologies Inc | HOLD | 0 @ USD 136.9 | USD 0 | The current share valuation price of A based on adjusted close was USD 136.9. The average price that A shares were previous bought at was USD 135.825. The current market price is 0.8% higher than average price they were purchased at. The value of the holding in A has increased by USD 13,971 compared to the previous valuation of Agilent Technologies Inc however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| ABBV - AbbVie Inc | HOLD | 0 @ USD 222.82 | USD 0 | The current share valuation price of ABBV based on adjusted close was USD 222.82. The average price that ABBV shares were previous bought at was USD 208.53. The current market price is 6.9% higher than average price they were purchased at. The value of the holding in ABBV has fallen by USD 229,363 compared to the previous valuation of AbbVie Inc |
| ABT - Abbott Laboratories | HOLD | 0 @ USD 125.12 | USD 0 | The current share valuation price of ABT based on adjusted close was USD 125.12. The average price that ABT shares were previous bought at was USD 131.201. The current market price is -4.6% lower than average price they were purchased at. The value of the holding in ABT has fallen by USD 147,080 compared to the previous valuation of Abbott Laboratories |
| ALC.SW - | HOLD | 0 @ CHF 80.2015 | CHF 0 | The current share valuation price of ALC.SW based on adjusted close was CHF 80.2015. The average price that ALC.SW shares were previous bought at was CHF 78.0142. The current market price is 2.8% higher than average price they were purchased at. The value of the holding in ALC.SW has increased by CHF 59,482 (USD $74,801) compared to the previous valuation of however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| ALNY - Alnylam Pharmaceuticals Inc | HOLD | 0 @ USD 396.04 | USD 0 | The current share valuation price of ALNY based on adjusted close was USD 396.04. The average price that ALNY shares were previous bought at was USD 419.366. The current market price is -5.6% lower than average price they were purchased at. The value of the holding in ALNY has increased by USD 43,871 compared to the previous valuation of Alnylam Pharmaceuticals Inc however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| AMGN - Amgen Inc | HOLD | 0 @ USD 324.42 | USD 0 | The current share valuation price of AMGN based on adjusted close was USD 324.42. The average price that AMGN shares were previous bought at was USD 304.386. The current market price is 6.6% higher than average price they were purchased at. The value of the holding in AMGN has fallen by USD 61,199 compared to the previous valuation of Amgen Inc |
| ARGX.BR - Argenx SE | HOLD | 0 @ EUR 853.726 | EUR 0 | The current share valuation price of ARGX.BR based on adjusted close was EUR 853.726. The average price that ARGX.BR shares were previous bought at was EUR 849.201. The current market price is 0.5% higher than average price they were purchased at. The value of the holding in ARGX.BR has fallen by EUR 105,050 (USD $123,353) compared to the previous valuation of Argenx SE |
| AZN.L - AstraZeneca PLC | HOLD | 0 @ GBP 181.462 | GBP 0 | The current share valuation price of AZN.L based on adjusted close was GBP 181.462. The average price that AZN.L shares were previous bought at was GBP 163.985. The current market price is 10.7% higher than average price they were purchased at. The value of the holding in AZN.L has fallen by GBP 23,560 (USD $31,511) compared to the previous valuation of AstraZeneca PLC |
| BAX - Baxter International Inc | HOLD | 0 @ USD 19.07 | USD 0 | The current share valuation price of BAX based on adjusted close was USD 19.07. The average price that BAX shares were previous bought at was USD 19.4921. The current market price is -2.2% lower than average price they were purchased at. The value of the holding in BAX has fallen by USD 3,597 compared to the previous valuation of Baxter International Inc |
| BAYN.DE - Bayer AG | HOLD | 0 @ EUR 41.3963 | EUR 0 | The current share valuation price of BAYN.DE based on adjusted close was EUR 41.3963. The average price that BAYN.DE shares were previous bought at was EUR 33.6975. The current market price is 22.8% higher than average price they were purchased at. The value of the holding in BAYN.DE has increased by EUR 2,777 (USD $3,261) compared to the previous valuation of Bayer AG however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| BDX - Becton Dickinson and Company | HOLD | 0 @ USD 194.7 | USD 0 | The current share valuation price of BDX based on adjusted close was USD 194.7. The average price that BDX shares were previous bought at was USD 185.934. The current market price is 4.7% higher than average price they were purchased at. The value of the holding in BDX has fallen by USD 4,134 compared to the previous valuation of Becton Dickinson and Company |
| BIIB - Biogen Inc | HOLD | 0 @ USD 169.91 | USD 0 | The current share valuation price of BIIB based on adjusted close was USD 169.91. The average price that BIIB shares were previous bought at was USD 173.989. The current market price is -2.3% lower than average price they were purchased at. The value of the holding in BIIB has fallen by USD 20,930 compared to the previous valuation of Biogen Inc |
| BIM.PA - BioMerieux | HOLD | 0 @ EUR 127.238 | EUR 0 | The current share valuation price of BIM.PA based on adjusted close was EUR 127.238. The average price that BIM.PA shares were previous bought at was EUR 126.886. The current market price is 0.3% higher than average price they were purchased at. The value of the holding in BIM.PA has fallen by EUR 725 (USD $851) compared to the previous valuation of BioMerieux |
| BMY - Bloomsbury Publishing Plc | HOLD | 0 @ USD 53.33 | USD 0 | The current share valuation price of BMY based on adjusted close was USD 53.33. The average price that BMY shares were previous bought at was USD 47.8225. The current market price is 11.5% higher than average price they were purchased at. The value of the holding in BMY has fallen by USD 28,997 compared to the previous valuation of Bloomsbury Publishing Plc |
| BSX - Boston Scientific Corporation | HOLD | 0 @ USD 96.11 | USD 0 | The current share valuation price of BSX based on adjusted close was USD 96.11. The average price that BSX shares were previous bought at was USD 99.851. The current market price is -3.7% lower than average price they were purchased at. The value of the holding in BSX has increased by USD 57,696 compared to the previous valuation of Boston Scientific Corporation however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| BSX - MULSTRXSSXIMETFP | HOLD | 0 @ USD 96.11 | USD 0 | The current share valuation price of BSX based on adjusted close was USD 96.11. The average price that BSX shares were previous bought at was USD 99.851. The current market price is -3.7% lower than average price they were purchased at. The value of the holding in BSX has increased by USD 57,696 compared to the previous valuation of MULSTRXSSXIMETFP however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| CAH - Cardinal Health Inc | HOLD | 0 @ USD 199.1 | USD 0 | The current share valuation price of CAH based on adjusted close was USD 199.1. The average price that CAH shares were previous bought at was USD 173.314. The current market price is 14.9% higher than average price they were purchased at. The value of the holding in CAH has increased by USD 34,077 compared to the previous valuation of Cardinal Health Inc however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| CI - Cigna Corp | HOLD | 0 @ USD 274 | USD 0 | The current share valuation price of CI based on adjusted close was USD 274. The average price that CI shares were previous bought at was USD 287.41. The current market price is -4.7% lower than average price they were purchased at. The value of the holding in CI has increased by USD 6,160 compared to the previous valuation of Cigna Corp however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| CNC - Concurrent Technologies Plc | HOLD | 0 @ USD 39.22 | USD 0 | The current share valuation price of CNC based on adjusted close was USD 39.22. The average price that CNC shares were previous bought at was USD 38.5786. The current market price is 1.7% higher than average price they were purchased at. The value of the holding in CNC has increased by USD 34,421 compared to the previous valuation of Concurrent Technologies Plc however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| COH.AX - | HOLD | 0 @ AUD 170.885 | AUD 0 | The current share valuation price of COH.AX based on adjusted close was AUD 170.885. The average price that COH.AX shares were previous bought at was AUD 183.354. The current market price is -6.8% lower than average price they were purchased at. The value of the holding in COH.AX has fallen by AUD 5,969 (USD $3,940) compared to the previous valuation of |
| COLO-B.CO - | HOLD | 0 @ DKK 85.2927 | DKK 0 | The current share valuation price of COLO-B.CO based on adjusted close was DKK 85.2927. The average price that COLO-B.CO shares were previous bought at was DKK 91.1232. The current market price is -6.4% lower than average price they were purchased at. The value of the holding in COLO-B.CO has fallen by DKK 57,697 (USD $9,069) compared to the previous valuation of |
| COO - The Cooper Companies, Inc. Common Stock | HOLD | 0 @ USD 82.46 | USD 0 | The current share valuation price of COO based on adjusted close was USD 82.46. The average price that COO shares were previous bought at was USD 76.0493. The current market price is 8.4% higher than average price they were purchased at. The value of the holding in COO has fallen by USD 396 compared to the previous valuation of The Cooper Companies, Inc. Common Stock |
| COR - Cencora Inc. | HOLD | 0 @ USD 340.58 | USD 0 | The current share valuation price of COR based on adjusted close was USD 340.58. The average price that COR shares were previous bought at was USD 325.675. The current market price is 4.6% higher than average price they were purchased at. The value of the holding in COR has fallen by USD 92,428 compared to the previous valuation of Cencora Inc. |
| CSL.AX - | HOLD | 0 @ AUD 115.103 | AUD 0 | The current share valuation price of CSL.AX based on adjusted close was AUD 115.103. The average price that CSL.AX shares were previous bought at was AUD 120.066. The current market price is -4.1% lower than average price they were purchased at. The value of the holding in CSL.AX has increased by AUD 12,726 (USD $8,401) compared to the previous valuation of however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| CVS - CVS Health Corp | HOLD | 0 @ USD 77.79 | USD 0 | The current share valuation price of CVS based on adjusted close was USD 77.79. The average price that CVS shares were previous bought at was USD 71.7416. The current market price is 8.4% higher than average price they were purchased at. The value of the holding in CVS has fallen by USD 7,148 compared to the previous valuation of CVS Health Corp |
| DEMANT.CO - | HOLD | 0 @ DKK 33.4013 | DKK 0 | The current share valuation price of DEMANT.CO based on adjusted close was DKK 33.4013. The average price that DEMANT.CO shares were previous bought at was DKK 35.2897. The current market price is -5.4% lower than average price they were purchased at. The value of the holding in DEMANT.CO has increased by DKK 8,001 (USD $1,258) compared to the previous valuation of however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| DGX - Quest Diagnostics Incorporated | HOLD | 0 @ USD 176.15 | USD 0 | The current share valuation price of DGX based on adjusted close was USD 176.15. The average price that DGX shares were previous bought at was USD 181.03. The current market price is -2.7% lower than average price they were purchased at. The value of the holding in DGX has fallen by USD 7,104 compared to the previous valuation of Quest Diagnostics Incorporated |
| DHR - Danaher Corporation | HOLD | 0 @ USD 224.35 | USD 0 | The current share valuation price of DHR based on adjusted close was USD 224.35. The average price that DHR shares were previous bought at was USD 211.186. The current market price is 6.2% higher than average price they were purchased at. The value of the holding in DHR has increased by USD 84,620 compared to the previous valuation of Danaher Corporation however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| DHR - Danaher Corporation | HOLD | 0 @ USD 224.35 | USD 0 | The current share valuation price of DHR based on adjusted close was USD 224.35. The average price that DHR shares were previous bought at was USD 211.186. The current market price is 6.2% higher than average price they were purchased at. The value of the holding in DHR has increased by USD 84,620 compared to the previous valuation of Danaher Corporation however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| DIM.PA - Sartorius Stedim Biotech | HOLD | 0 @ EUR 238.879 | EUR 0 | The current share valuation price of DIM.PA based on adjusted close was EUR 238.879. The average price that DIM.PA shares were previous bought at was EUR 223.9. The current market price is 6.7% higher than average price they were purchased at. The value of the holding in DIM.PA has fallen by EUR 1,178 (USD $1,383) compared to the previous valuation of Sartorius Stedim Biotech |
| DXCM - DexCom Inc | HOLD | 0 @ USD 65.91 | USD 0 | The current share valuation price of DXCM based on adjusted close was USD 65.91. The average price that DXCM shares were previous bought at was USD 68.9681. The current market price is -4.4% lower than average price they were purchased at. The value of the holding in DXCM has increased by USD 1,971 compared to the previous valuation of DexCom Inc however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| EL.PA - EssilorLuxottica SA | HOLD | 0 @ EUR 324.017 | EUR 0 | The current share valuation price of EL.PA based on adjusted close was EUR 324.017. The average price that EL.PA shares were previous bought at was EUR 342.345. The current market price is -5.4% lower than average price they were purchased at. The value of the holding in EL.PA has increased by EUR 55,528 (USD $65,203) compared to the previous valuation of EssilorLuxottica SA however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| ELV - Elevance Health Inc | HOLD | 0 @ USD 344.6 | USD 0 | The current share valuation price of ELV based on adjusted close was USD 344.6. The average price that ELV shares were previous bought at was USD 338.366. The current market price is 1.8% higher than average price they were purchased at. The value of the holding in ELV has fallen by USD 49,831 compared to the previous valuation of Elevance Health Inc |
| ELV - Elevance Health Inc | HOLD | 0 @ USD 344.6 | USD 0 | The current share valuation price of ELV based on adjusted close was USD 344.6. The average price that ELV shares were previous bought at was USD 338.366. The current market price is 1.8% higher than average price they were purchased at. The value of the holding in ELV has fallen by USD 49,831 compared to the previous valuation of Elevance Health Inc |
| ERF.PA - Eurofins Scientific SE | HOLD | 0 @ EUR 72.3086 | EUR 0 | The current share valuation price of ERF.PA based on adjusted close was EUR 72.3086. The average price that ERF.PA shares were previous bought at was EUR 69.0799. The current market price is 4.7% higher than average price they were purchased at. The value of the holding in ERF.PA has increased by EUR 11,900 (USD $13,973) compared to the previous valuation of Eurofins Scientific SE however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| EW - Edwards Lifesciences Corp | HOLD | 0 @ USD 84.8 | USD 0 | The current share valuation price of EW based on adjusted close was USD 84.8. The average price that EW shares were previous bought at was USD 80.0235. The current market price is 6.0% higher than average price they were purchased at. The value of the holding in EW has fallen by USD 4,038 compared to the previous valuation of Edwards Lifesciences Corp |
| FME.DE - Fresenius Medical Care AG | HOLD | 0 @ EUR 47.2364 | EUR 0 | The current share valuation price of FME.DE based on adjusted close was EUR 47.2364. The average price that FME.DE shares were previous bought at was EUR 49.9034. The current market price is -5.3% lower than average price they were purchased at. The value of the holding in FME.DE has fallen by EUR 789 (USD $926) compared to the previous valuation of Fresenius Medical Care AG |
| FPH.NZ - | HOLD | 0 @ NZD 21.3266 | NZD 0 | The current share valuation price of FPH.NZ based on adjusted close was NZD 21.3266. The average price that FPH.NZ shares were previous bought at was NZD 21.3251. The current market price is 0.0% higher than average price they were purchased at. The value of the holding in FPH.NZ has fallen by NZD 2,716 (USD $1,568) compared to the previous valuation of |
| FRE.DE - Fresenius SE & Co KGaA | HOLD | 0 @ EUR 56.1957 | EUR 0 | The current share valuation price of FRE.DE based on adjusted close was EUR 56.1957. The average price that FRE.DE shares were previous bought at was EUR 53.0548. The current market price is 5.9% higher than average price they were purchased at. The value of the holding in FRE.DE has increased by EUR 325 (USD $382) compared to the previous valuation of Fresenius SE & Co KGaA however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| GALD.SW - | HOLD | 0 @ CHF 207.557 | CHF 0 | The current share valuation price of GALD.SW based on adjusted close was CHF 207.557. The average price that GALD.SW shares were previous bought at was CHF 186.072. The current market price is 11.5% higher than average price they were purchased at. The value of the holding in GALD.SW has increased by CHF 31,331 (USD $39,400) compared to the previous valuation of however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| GEHC - GE HealthCare Technologies Inc. | HOLD | 0 @ USD 82.52 | USD 0 | The current share valuation price of GEHC based on adjusted close was USD 82.52. The average price that GEHC shares were previous bought at was USD 77.1977. The current market price is 6.9% higher than average price they were purchased at. The value of the holding in GEHC has increased by USD 1,435 compared to the previous valuation of GE HealthCare Technologies Inc. however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| GILD - Guild Esports Plc | HOLD | 0 @ USD 121.47 | USD 0 | The current share valuation price of GILD based on adjusted close was USD 121.47. The average price that GILD shares were previous bought at was USD 117.192. The current market price is 3.7% higher than average price they were purchased at. The value of the holding in GILD has increased by USD 16,943 compared to the previous valuation of Guild Esports Plc however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| GMAB.CO - | HOLD | 0 @ DKK 314.55 | DKK 0 | The current share valuation price of GMAB.CO based on adjusted close was DKK 314.55. The average price that GMAB.CO shares were previous bought at was DKK 286.791. The current market price is 9.7% higher than average price they were purchased at. The value of the holding in GMAB.CO has fallen by DKK 41,771 (USD $6,566) compared to the previous valuation of |
| GRF.MC - Grifols SA | HOLD | 0 @ EUR 12.6593 | EUR 0 | The current share valuation price of GRF.MC based on adjusted close was EUR 12.6593. The average price that GRF.MC shares were previous bought at was EUR 13.0441. The current market price is -2.9% lower than average price they were purchased at. The value of the holding in GRF.MC has increased by EUR 2,518 (USD $2,957) compared to the previous valuation of Grifols SA however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| GSK.L - GlaxoSmithKline PLC | HOLD | 0 @ GBP 24.2766 | GBP 0 | The current share valuation price of GSK.L based on adjusted close was GBP 24.2766. The average price that GSK.L shares were previous bought at was GBP 23.3517. The current market price is 4.0% higher than average price they were purchased at. The value of the holding in GSK.L has fallen by GBP 64,934 (USD $86,847) compared to the previous valuation of GlaxoSmithKline PLC |
| HCA - HCA Holdings Inc | HOLD | 0 @ USD 466.56 | USD 0 | The current share valuation price of HCA based on adjusted close was USD 466.56. The average price that HCA shares were previous bought at was USD 448.598. The current market price is 4.0% higher than average price they were purchased at. The value of the holding in HCA has fallen by USD 22,107 compared to the previous valuation of HCA Holdings Inc |
| HIK.L - | HOLD | 0 @ GBP 20.225 | GBP 0 | The current share valuation price of HIK.L based on adjusted close was GBP 20.225. The average price that HIK.L shares were previous bought at was GBP 22.6187. The current market price is -10.6% lower than average price they were purchased at. The value of the holding in HIK.L has fallen by GBP 916 (USD $1,225) compared to the previous valuation of |
| HLN.L - Haleon PLC | HOLD | 0 @ GBP 4.96114 | GBP 0 | The current share valuation price of HLN.L based on adjusted close was GBP 4.96114. The average price that HLN.L shares were previous bought at was GBP 4.88757. The current market price is 1.5% higher than average price they were purchased at. The value of the holding in HLN.L has increased by GBP 4,115 (USD $5,504) compared to the previous valuation of Haleon PLC however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| HOLX - Hologic Inc | HOLD | 0 @ USD 74.94 | USD 0 | The current share valuation price of HOLX based on adjusted close was USD 74.94. The average price that HOLX shares were previous bought at was USD 70.9179. The current market price is 5.7% higher than average price they were purchased at. The value of the holding in HOLX has increased by USD 823 compared to the previous valuation of Hologic Inc however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| HUM - Hummingbird Resources PLC | HOLD | 0 @ USD 260.67 | USD 0 | The current share valuation price of HUM based on adjusted close was USD 260.67. The average price that HUM shares were previous bought at was USD 265.443. The current market price is -1.8% lower than average price they were purchased at. The value of the holding in HUM has increased by USD 7,201 compared to the previous valuation of Hummingbird Resources PLC however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| HUM - Humana Inc | HOLD | 0 @ USD 260.67 | USD 0 | The current share valuation price of HUM based on adjusted close was USD 260.67. The average price that HUM shares were previous bought at was USD 265.443. The current market price is -1.8% lower than average price they were purchased at. The value of the holding in HUM has increased by USD 7,201 compared to the previous valuation of Humana Inc however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| IDXX - IDEXX Laboratories Inc | HOLD | 0 @ USD 697.1 | USD 0 | The current share valuation price of IDXX based on adjusted close was USD 697.1. The average price that IDXX shares were previous bought at was USD 631.412. The current market price is 10.4% higher than average price they were purchased at. The value of the holding in IDXX has increased by USD 24,001 compared to the previous valuation of IDEXX Laboratories Inc however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| ILMN - Illumina Inc | HOLD | 0 @ USD 130.51 | USD 0 | The current share valuation price of ILMN based on adjusted close was USD 130.51. The average price that ILMN shares were previous bought at was USD 110.231. The current market price is 18.4% higher than average price they were purchased at. The value of the holding in ILMN has increased by USD 3,237 compared to the previous valuation of Illumina Inc however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| INCY - Incyte Corporation | HOLD | 0 @ USD 97.31 | USD 0 | The current share valuation price of INCY based on adjusted close was USD 97.31. The average price that INCY shares were previous bought at was USD 103.304. The current market price is -5.8% lower than average price they were purchased at. The value of the holding in INCY has fallen by USD 4,175 compared to the previous valuation of Incyte Corporation |
| INSM - Insmed Inc | HOLD | 0 @ USD 166.55 | USD 0 | The current share valuation price of INSM based on adjusted close was USD 166.55. The average price that INSM shares were previous bought at was USD 200.537. The current market price is -16.9% lower than average price they were purchased at. The value of the holding in INSM has fallen by USD 382,154 compared to the previous valuation of Insmed Inc |
| IPN.PA - Ipsen SA | HOLD | 0 @ EUR 140.841 | EUR 0 | The current share valuation price of IPN.PA based on adjusted close was EUR 140.841. The average price that IPN.PA shares were previous bought at was EUR 136.726. The current market price is 3.0% higher than average price they were purchased at. The value of the holding in IPN.PA has fallen by EUR 741 (USD $870) compared to the previous valuation of Ipsen SA |
| IQV - IQVIA Holdings Inc | HOLD | 0 @ USD 222.52 | USD 0 | The current share valuation price of IQV based on adjusted close was USD 222.52. The average price that IQV shares were previous bought at was USD 201.139. The current market price is 10.6% higher than average price they were purchased at. The value of the holding in IQV has increased by USD 47,446 compared to the previous valuation of IQVIA Holdings Inc however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| ISRG - Intuitive Surgical Inc | HOLD | 0 @ USD 561.89 | USD 0 | The current share valuation price of ISRG based on adjusted close was USD 561.89. The average price that ISRG shares were previous bought at was USD 539.91. The current market price is 4.1% higher than average price they were purchased at. The value of the holding in ISRG has increased by USD 129,819 compared to the previous valuation of Intuitive Surgical Inc however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| JNJ - Johnson & Johnson | HOLD | 0 @ USD 208.31 | USD 0 | The current share valuation price of JNJ based on adjusted close was USD 208.31. The average price that JNJ shares were previous bought at was USD 172.38. The current market price is 20.8% higher than average price they were purchased at. The value of the holding in JNJ has fallen by USD 323,379 compared to the previous valuation of Johnson & Johnson |
| LH - Laboratory Corporation of America Holdings | HOLD | 0 @ USD 252.03 | USD 0 | The current share valuation price of LH based on adjusted close was USD 252.03. The average price that LH shares were previous bought at was USD 262.154. The current market price is -3.9% lower than average price they were purchased at. The value of the holding in LH has fallen by USD 6,952 compared to the previous valuation of Laboratory Corporation of America Holdings |
| LLY - Eli Lilly and Company | HOLD | 0 @ USD 1056.88 | USD 0 | The current share valuation price of LLY based on adjusted close was USD 1056.88. The average price that LLY shares were previous bought at was USD 871.319. The current market price is 21.3% higher than average price they were purchased at. The value of the holding in LLY has increased by USD 1,050,580 compared to the previous valuation of Eli Lilly and Company however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| LONN.SW - | HOLD | 0 @ CHF 667.758 | CHF 0 | The current share valuation price of LONN.SW based on adjusted close was CHF 667.758. The average price that LONN.SW shares were previous bought at was CHF 673.272. The current market price is -0.8% lower than average price they were purchased at. The value of the holding in LONN.SW has increased by CHF 13,577 (USD $17,074) compared to the previous valuation of however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| MCK - McKesson Corporation | HOLD | 0 @ USD 810.56 | USD 0 | The current share valuation price of MCK based on adjusted close was USD 810.56. The average price that MCK shares were previous bought at was USD 786.762. The current market price is 3.0% higher than average price they were purchased at. The value of the holding in MCK has increased by USD 66,587 compared to the previous valuation of McKesson Corporation however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| MDT - Medtronic PLC | HOLD | 0 @ USD 98.48 | USD 0 | The current share valuation price of MDT based on adjusted close was USD 98.48. The average price that MDT shares were previous bought at was USD 97.6582. The current market price is 0.8% higher than average price they were purchased at. The value of the holding in MDT has increased by USD 6,469 compared to the previous valuation of Medtronic PLC however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| MRK - Marks Electrical Group PLC | HOLD | 0 @ USD 100.69 | USD 0 | The current share valuation price of MRK based on adjusted close was USD 100.69. The average price that MRK shares were previous bought at was USD 85.2551. The current market price is 18.1% higher than average price they were purchased at. The value of the holding in MRK has increased by USD 278,549 compared to the previous valuation of Marks Electrical Group PLC however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| MRK - Merck & Company Inc | HOLD | 0 @ USD 100.69 | USD 0 | The current share valuation price of MRK based on adjusted close was USD 100.69. The average price that MRK shares were previous bought at was USD 85.2551. The current market price is 18.1% higher than average price they were purchased at. The value of the holding in MRK has increased by USD 278,549 compared to the previous valuation of Merck & Company Inc however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| MRK.DE - Merck KGaA | HOLD | 0 @ EUR 139.375 | EUR 0 | The current share valuation price of MRK.DE based on adjusted close was EUR 139.375. The average price that MRK.DE shares were previous bought at was EUR 132.943. The current market price is 4.8% higher than average price they were purchased at. The value of the holding in MRK.DE has fallen by EUR 2,574 (USD $3,022) compared to the previous valuation of Merck KGaA |
| MTD - Mettler-Toledo International Inc | HOLD | 0 @ USD 1389.42 | USD 0 | The current share valuation price of MTD based on adjusted close was USD 1389.42. The average price that MTD shares were previous bought at was USD 1459.22. The current market price is -4.8% lower than average price they were purchased at. The value of the holding in MTD has increased by USD 11,670 compared to the previous valuation of Mettler-Toledo International Inc however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| MTD - AMUNDI EUR GOV 710 | HOLD | 0 @ USD 1389.42 | USD 0 | The current share valuation price of MTD based on adjusted close was USD 1389.42. The average price that MTD shares were previous bought at was USD 1459.22. The current market price is -4.8% lower than average price they were purchased at. The value of the holding in MTD has increased by USD 11,670 compared to the previous valuation of AMUNDI EUR GOV 710 however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| NBIX - Neurocrine Biosciences Inc | HOLD | 0 @ USD 141.84 | USD 0 | The current share valuation price of NBIX based on adjusted close was USD 141.84. The average price that NBIX shares were previous bought at was USD 143.035. The current market price is -0.8% lower than average price they were purchased at. The value of the holding in NBIX has increased by USD 282 compared to the previous valuation of Neurocrine Biosciences Inc however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| NOVN.SW - | HOLD | 0 @ CHF 135.693 | CHF 0 | The current share valuation price of NOVN.SW based on adjusted close was CHF 135.693. The average price that NOVN.SW shares were previous bought at was CHF 126.237. The current market price is 7.5% higher than average price they were purchased at. The value of the holding in NOVN.SW has fallen by CHF 47,717 (USD $60,006) compared to the previous valuation of |
| NOVO-B.CO - Novo Nordisk A/S | HOLD | 0 @ DKK 47.7633 | DKK 0 | The current share valuation price of NOVO-B.CO based on adjusted close was DKK 47.7633. The average price that NOVO-B.CO shares were previous bought at was DKK 54.2313. The current market price is -11.9% lower than average price they were purchased at. The value of the holding in NOVO-B.CO has fallen by DKK 224,077 (USD $35,220) compared to the previous valuation of Novo Nordisk A/S |
| NTRA - Natera Inc | HOLD | 0 @ USD 224.74 | USD 0 | The current share valuation price of NTRA based on adjusted close was USD 224.74. The average price that NTRA shares were previous bought at was USD 182.339. The current market price is 23.3% higher than average price they were purchased at. The value of the holding in NTRA has fallen by USD 2,495 compared to the previous valuation of Natera Inc |
| ORNBV.HE - Orion Oyj | HOLD | 0 @ EUR 71.8864 | EUR 0 | The current share valuation price of ORNBV.HE based on adjusted close was EUR 71.8864. The average price that ORNBV.HE shares were previous bought at was EUR 68.5395. The current market price is 4.9% higher than average price they were purchased at. The value of the holding in ORNBV.HE has increased by EUR 2,646 (USD $3,107) compared to the previous valuation of Orion Oyj however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| PFE - Pfizer Inc | HOLD | 0 @ USD 25.04 | USD 0 | The current share valuation price of PFE based on adjusted close was USD 25.04. The average price that PFE shares were previous bought at was USD 24.8545. The current market price is 0.7% higher than average price they were purchased at. USD 0 compared to the previous valuation of Pfizer Inc however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| PHIA.AS - Koninklijke Philips NV | HOLD | 0 @ EUR 26.7259 | EUR 0 | The current share valuation price of PHIA.AS based on adjusted close was EUR 26.7259. The average price that PHIA.AS shares were previous bought at was EUR 26.6032. The current market price is 0.5% higher than average price they were purchased at. The value of the holding in PHIA.AS has increased by EUR 7,935 (USD $9,318) compared to the previous valuation of Koninklijke Philips NV however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| PME.AX - | HOLD | 0 @ AUD 142.14 | AUD 0 | The current share valuation price of PME.AX based on adjusted close was AUD 142.14. The average price that PME.AX shares were previous bought at was AUD 174.833. The current market price is -18.7% lower than average price they were purchased at. The value of the holding in PME.AX has fallen by AUD 4,908 (USD $3,240) compared to the previous valuation of |
| PODD - Insulet Corporation | HOLD | 0 @ USD 292.88 | USD 0 | The current share valuation price of PODD based on adjusted close was USD 292.88. The average price that PODD shares were previous bought at was USD 329.597. The current market price is -11.1% lower than average price they were purchased at. The value of the holding in PODD has increased by USD 10,529 compared to the previous valuation of Insulet Corporation however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| QIA.DE - QIAGEN NV | HOLD | 0 @ EUR 45.0844 | EUR 0 | The current share valuation price of QIA.DE based on adjusted close was EUR 45.0844. The average price that QIA.DE shares were previous bought at was EUR 45.7032. The current market price is -1.4% lower than average price they were purchased at. The value of the holding in QIA.DE has fallen by EUR 13,672 (USD $16,054) compared to the previous valuation of QIAGEN NV |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | HOLD | 0 @ EUR 56.9464 | EUR 0 | The current share valuation price of REC.MI based on adjusted close was EUR 56.9464. The average price that REC.MI shares were previous bought at was EUR 58.209. The current market price is -2.2% lower than average price they were purchased at. The value of the holding in REC.MI has fallen by EUR 82 (USD $96) compared to the previous valuation of Recordati Industria Chimica e Farmaceutica SpA |
| REGN - Regeneron Pharmaceuticals Inc | HOLD | 0 @ USD 748.71 | USD 0 | The current share valuation price of REGN based on adjusted close was USD 748.71. The average price that REGN shares were previous bought at was USD 715.253. The current market price is 4.7% higher than average price they were purchased at. The value of the holding in REGN has fallen by USD 7,776 compared to the previous valuation of Regeneron Pharmaceuticals Inc |
| RMD - ResMed Inc | HOLD | 0 @ USD 242.55 | USD 0 | The current share valuation price of RMD based on adjusted close was USD 242.55. The average price that RMD shares were previous bought at was USD 255.221. The current market price is -5.0% lower than average price they were purchased at. The value of the holding in RMD has fallen by USD 14,825 compared to the previous valuation of ResMed Inc |
| RO.SW - | HOLD | 0 @ CHF 415.617 | CHF 0 | The current share valuation price of RO.SW based on adjusted close was CHF 415.617. The average price that RO.SW shares were previous bought at was CHF 347.062. The current market price is 19.8% higher than average price they were purchased at. The value of the holding in RO.SW has increased by CHF 41,079 (USD $51,659) compared to the previous valuation of however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| ROG.SW - | HOLD | 0 @ CHF 402.393 | CHF 0 | The current share valuation price of ROG.SW based on adjusted close was CHF 402.393. The average price that ROG.SW shares were previous bought at was CHF 362.815. The current market price is 10.9% higher than average price they were purchased at. The value of the holding in ROG.SW has increased by CHF 158,575 (USD $199,415) compared to the previous valuation of however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| RPRX - Royalty Pharma Plc | HOLD | 0 @ USD 38.43 | USD 0 | The current share valuation price of RPRX based on adjusted close was USD 38.43. The average price that RPRX shares were previous bought at was USD 37.2888. The current market price is 3.1% higher than average price they were purchased at. The value of the holding in RPRX has increased by USD 1,070 compared to the previous valuation of Royalty Pharma Plc however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| SAN.PA - Sanofi SA | HOLD | 0 @ EUR 96.2787 | EUR 0 | The current share valuation price of SAN.PA based on adjusted close was EUR 96.2787. The average price that SAN.PA shares were previous bought at was EUR 98.7753. The current market price is -2.5% lower than average price they were purchased at. The value of the holding in SAN.PA has fallen by EUR 14,434 (USD $16,949) compared to the previous valuation of Sanofi SA |
| SDZ.SW - | HOLD | 0 @ CHF 73.1486 | CHF 0 | The current share valuation price of SDZ.SW based on adjusted close was CHF 73.1486. The average price that SDZ.SW shares were previous bought at was CHF 60.4305. The current market price is 21.0% higher than average price they were purchased at. The value of the holding in SDZ.SW has increased by CHF 7,787 (USD $9,793) compared to the previous valuation of however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| SHL.AX - | HOLD | 0 @ AUD 14.8981 | AUD 0 | The current share valuation price of SHL.AX based on adjusted close was AUD 14.8981. The average price that SHL.AX shares were previous bought at was AUD 15.0907. The current market price is -1.3% lower than average price they were purchased at. The value of the holding in SHL.AX has increased by AUD 199 (USD $131) compared to the previous valuation of however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| SHL.DE - Siemens Healthineers AG | HOLD | 0 @ EUR 52.4432 | EUR 0 | The current share valuation price of SHL.DE based on adjusted close was EUR 52.4432. The average price that SHL.DE shares were previous bought at was EUR 53.1451. The current market price is -1.3% lower than average price they were purchased at. The value of the holding in SHL.DE has fallen by EUR 220 (USD $258) compared to the previous valuation of Siemens Healthineers AG |
| SIG.AX - | HOLD | 0 @ AUD 1.9185 | AUD 0 | The current share valuation price of SIG.AX based on adjusted close was AUD 1.9185. The average price that SIG.AX shares were previous bought at was AUD 1.89939. The current market price is 1.0% higher than average price they were purchased at. The value of the holding in SIG.AX has fallen by AUD 17,715 (USD $11,695) compared to the previous valuation of |
| SN.L - Smith & Nephew PLC | HOLD | 0 @ GBP 16.4813 | GBP 0 | The current share valuation price of SN.L based on adjusted close was GBP 16.4813. The average price that SN.L shares were previous bought at was GBP 17.0453. The current market price is -3.3% lower than average price they were purchased at. The value of the holding in SN.L has increased by GBP 1,745 (USD $2,334) compared to the previous valuation of Smith & Nephew PLC however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| SOBI.ST - | HOLD | 0 @ SEK 34.9115 | SEK 0 | The current share valuation price of SOBI.ST based on adjusted close was SEK 34.9115. The average price that SOBI.ST shares were previous bought at was SEK 33.1538. The current market price is 5.3% higher than average price they were purchased at. The value of the holding in SOBI.ST has fallen by SEK 2,690 (USD $289) compared to the previous valuation of |
| SOLV - Solventum Corp. | HOLD | 0 @ USD 80.6801 | USD 0 | The current share valuation price of SOLV based on adjusted close was USD 80.6801. The average price that SOLV shares were previous bought at was USD 74.1118. The current market price is 8.9% higher than average price they were purchased at. The value of the holding in SOLV has increased by USD 3,035 compared to the previous valuation of Solventum Corp. however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| SOON.SW - | HOLD | 0 @ CHF 260.076 | CHF 0 | The current share valuation price of SOON.SW based on adjusted close was CHF 260.076. The average price that SOON.SW shares were previous bought at was CHF 270.65. The current market price is -3.9% lower than average price they were purchased at. The value of the holding in SOON.SW has increased by CHF 20,188 (USD $25,387) compared to the previous valuation of however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| SRT3.DE - Sartorius AG | HOLD | 0 @ EUR 278.516 | EUR 0 | The current share valuation price of SRT3.DE based on adjusted close was EUR 278.516. The average price that SRT3.DE shares were previous bought at was EUR 260.473. The current market price is 6.9% higher than average price they were purchased at. The value of the holding in SRT3.DE has increased by EUR 3,693 (USD $4,336) compared to the previous valuation of Sartorius AG however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| STE - STERIS plc | HOLD | 0 @ USD 251.55 | USD 0 | The current share valuation price of STE based on adjusted close was USD 251.55. The average price that STE shares were previous bought at was USD 244.356. The current market price is 2.9% higher than average price they were purchased at. The value of the holding in STE has fallen by USD 4,194 compared to the previous valuation of STERIS plc |
| STMN.SW - | HOLD | 0 @ CHF 118.917 | CHF 0 | The current share valuation price of STMN.SW based on adjusted close was CHF 118.917. The average price that STMN.SW shares were previous bought at was CHF 121.328. The current market price is -2.0% lower than average price they were purchased at. The value of the holding in STMN.SW has fallen by CHF 2,806 (USD $3,529) compared to the previous valuation of |
| SYK - Stryker Corporation | HOLD | 0 @ USD 353.11 | USD 0 | The current share valuation price of SYK based on adjusted close was USD 353.11. The average price that SYK shares were previous bought at was USD 368.927. The current market price is -4.3% lower than average price they were purchased at. The value of the holding in SYK has increased by USD 8,890 compared to the previous valuation of Stryker Corporation however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| TEVA - Teva Pharma Industries Ltd ADR | HOLD | 0 @ USD 30.32 | USD 0 | The current share valuation price of TEVA based on adjusted close was USD 30.32. The average price that TEVA shares were previous bought at was USD 20.8434. The current market price is 45.5% higher than average price they were purchased at. The value of the holding in TEVA has increased by USD 6,501 compared to the previous valuation of Teva Pharma Industries Ltd ADR however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| TMO - Time Out Group plc | HOLD | 0 @ USD 562.39 | USD 0 | The current share valuation price of TMO based on adjusted close was USD 562.39. The average price that TMO shares were previous bought at was USD 485.507. The current market price is 15.8% higher than average price they were purchased at. The value of the holding in TMO has fallen by USD 3,902 compared to the previous valuation of Time Out Group plc |
| UCB.BR - UCB SA | HOLD | 0 @ EUR 277.226 | EUR 0 | The current share valuation price of UCB.BR based on adjusted close was EUR 277.226. The average price that UCB.BR shares were previous bought at was EUR 256.041. The current market price is 8.3% higher than average price they were purchased at. The value of the holding in UCB.BR has increased by EUR 20,014 (USD $23,501) compared to the previous valuation of UCB SA however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| UNH - UnitedHealth Group Incorporated | HOLD | 0 @ USD 328.14 | USD 0 | The current share valuation price of UNH based on adjusted close was USD 328.14. The average price that UNH shares were previous bought at was USD 322.008. The current market price is 1.9% higher than average price they were purchased at. The value of the holding in UNH has fallen by USD 253,531 compared to the previous valuation of UnitedHealth Group Incorporated |
| UTHR - United Therapeutics Corporation | HOLD | 0 @ USD 507 | USD 0 | The current share valuation price of UTHR based on adjusted close was USD 507. The average price that UTHR shares were previous bought at was USD 437.623. The current market price is 15.9% higher than average price they were purchased at. The value of the holding in UTHR has fallen by USD 3,842 compared to the previous valuation of United Therapeutics Corporation |
| VEEV - Veeva Systems Inc Class A | HOLD | 0 @ USD 218.1 | USD 0 | The current share valuation price of VEEV based on adjusted close was USD 218.1. The average price that VEEV shares were previous bought at was USD 270.663. The current market price is -19.4% lower than average price they were purchased at. The value of the holding in VEEV has increased by USD 77,587 compared to the previous valuation of Veeva Systems Inc Class A however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |
| VRTX - Vertex Pharmaceuticals Inc | HOLD | 0 @ USD 447.38 | USD 0 | The current share valuation price of VRTX based on adjusted close was USD 447.38. The average price that VRTX shares were previous bought at was USD 429.125. The current market price is 4.3% higher than average price they were purchased at. The value of the holding in VRTX has fallen by USD 70,386 compared to the previous valuation of Vertex Pharmaceuticals Inc |
| WAT - Waters Corporation | HOLD | 0 @ USD 376.31 | USD 0 | The current share valuation price of WAT based on adjusted close was USD 376.31. The average price that WAT shares were previous bought at was USD 347.396. The current market price is 8.3% higher than average price they were purchased at. The value of the holding in WAT has fallen by USD 13,553 compared to the previous valuation of Waters Corporation |
| WAT - MULETFWATIMETFP | HOLD | 0 @ USD 376.31 | USD 0 | The current share valuation price of WAT based on adjusted close was USD 376.31. The average price that WAT shares were previous bought at was USD 347.396. The current market price is 8.3% higher than average price they were purchased at. The value of the holding in WAT has fallen by USD 13,553 compared to the previous valuation of MULETFWATIMETFP |
| WST - West Pharmaceutical Services Inc | HOLD | 0 @ USD 268.66 | USD 0 | The current share valuation price of WST based on adjusted close was USD 268.66. The average price that WST shares were previous bought at was USD 265.622. The current market price is 1.1% higher than average price they were purchased at. The value of the holding in WST has fallen by USD 767 compared to the previous valuation of West Pharmaceutical Services Inc |
| ZBH - Zimmer Biomet Holdings Inc | HOLD | 0 @ USD 90.4 | USD 0 | The current share valuation price of ZBH based on adjusted close was USD 90.4. The average price that ZBH shares were previous bought at was USD 96.0496. The current market price is -5.9% lower than average price they were purchased at. The value of the holding in ZBH has fallen by USD 5,309 compared to the previous valuation of Zimmer Biomet Holdings Inc |
| ZTS - Zoetis Inc | HOLD | 0 @ USD 122.76 | USD 0 | The current share valuation price of ZTS based on adjusted close was USD 122.76. The average price that ZTS shares were previous bought at was USD 135.147. The current market price is -9.2% lower than average price they were purchased at. The value of the holding in ZTS has increased by USD 47,002 compared to the previous valuation of Zoetis Inc however if the holding was sold on 2025-12-18 this would crystalise an overall loss. |